移植物抗宿主病(graft versus host disease)简称GVHD。是由于移植物的抗宿主反应而引起的一种免疫性疾病。分急性和慢性二种。 诊断要点: 1.急性移植物抗宿主病:发病在移植后7-30天,有发热、食欲不振、腹泻、腹痛、呕吐和肝脏损害等。 皮肤上发生充血性弥漫性皮疹,有的可呈麻疹样或猩红热样,极少数表现为大疱性...
Graft-versus-host diseaseis a complication of bone marrow transplantation and a major cause of morbidity and mortality in the transplant population. Numerous musculoskeletal symptoms arise in the setting of acute graft-versus-host disease (lasting 0 to 3 months) and in chronic graft-versus-host dis...
15 2 一,概述 (一)前言 移植物抗宿主病(graft-versus-host disease, GvHD)是异基因 造血干细胞移植(allogeneic hematopoietic stem cell transplantation, Allo-HSCT)后,受者在重建供者免疫的过程中,来源于供者的 淋巴细胞攻击受者组织发生的一类多器官综合征,表现为主要 累及皮肤,胃肠道,肝,肺和黏膜表面的组织...
一,起草目的 移植物抗宿主病(graft-versus-host disease, GvHD)是异 基因造血干细胞移植术后并发症和非复发性死亡的主要原 因,防治 GvHD 对保证移植成功及移植后长期生存有重要意 义.间充质干细胞治疗 GvHD 的临床试验进展较为迅速.目 前国内外无相关的临床试验技术指导原则,为提供关于间充 质干细胞防治移植物...
移植物抗宿主病(graft—versus-host disease,GVHD):在骨髓移植时,用作移植的骨髓中常常混含供者T淋巴细胞,这些细胞与受者同种异型抗原发生应答,引起皮肤、肝、肠道等上皮细胞坏死,严重可致死亡。结果一 题目 植物抗宿主病〔graft-versus-host disease,GVHD〕 答案 移植物抗宿主病〔graft-versus-host disease,GVHD...
Related to Graft vs host disease:cGVHD graft-ver·sus-host disease (grăft′vûr′səs-hōst′, -səz-) n. A condition in which cells from the transplanted tissue of a donor initiate an immunologic attack on the cells and tissue of the recipient. ...
maculareruptiononhertrunk,andarm.Sheexperiencedflu-likesymptoms,intermittentmilddiarrhea,andintra-oralulcerationsaswellaschronicallydry,irritatedeyes.Shewasinitiallytreatedwithfluocinonideointmenttwicedaily.Overthenextseveralmonthstheeruptionevolvedintoreticulated,hyperpigmentedpatchesoverlyinghertrunk,arms,andlegs.Ten...
一,起草目的 移植物抗宿主病(graft-versus-host disease, GvHD)是异 基因造血干细胞移植术后并发症和非复发性死亡的主要原 因,防治 GvHD 对保证移植成功及移植后长期生存有重要意 义.间充质干细胞治疗 GvHD 的临床试验进展较为迅速.目 前国内外无相关的临床试验技术指导原则,为提供关于间充 质干细胞防治移植物...
Synonym: GVH disease. Acronym: GVHD 分析总结。 下载app视频解答结果一 题目 “Graft-Versus-Host Disease”这是什么病呢?求中文译名, 答案 中文名:移植物抗宿主病下面是英语解释A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a...
Graft-vs.-host disease (GVHD) remains a major complication of allogeneic BMT, occurring in 25% to 70% of patients despite GVHD prophylaxis, with the skin, gastro-intestinal tract, and liver as primary target organs. Oral findings are seen in both acute and chronic GVHD. In acute GVHD, ...